Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators.
Journal
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
ISSN: 1740-634X
Titre abrégé: Neuropsychopharmacology
Pays: England
ID NLM: 8904907
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
31
08
2022
accepted:
26
12
2022
revised:
21
12
2022
medline:
5
5
2023
pubmed:
13
1
2023
entrez:
12
1
2023
Statut:
ppublish
Résumé
Chronic inflammation has been implicated in the pathophysiology of major depressive disorder (MDD). Activating the resolution of inflammation through ω-3 fatty acid supplementation may prove to be a successful therapeutic strategy for the treatment of MDD. Patients with MDD, body mass index >25 kg/m
Identifiants
pubmed: 36635595
doi: 10.1038/s41386-022-01527-7
pii: 10.1038/s41386-022-01527-7
pmc: PMC10156711
doi:
Substances chimiques
Eicosapentaenoic Acid
AAN7QOV9EA
Docosahexaenoic Acids
25167-62-8
Fatty Acids, Omega-3
0
C-Reactive Protein
9007-41-4
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
929-935Subventions
Organisme : NCCIH NIH HHS
ID : UG3 AT008857
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
FASEB J. 2019 Jun;33(6):7072-7083
pubmed: 30840838
J Lipid Res. 2013 Sep;54(9):2410-22
pubmed: 23836105
Psychol Med. 1996 May;26(3):477-86
pubmed: 8733206
J Clin Psychiatry. 2014 Dec;75(12):e1428-32
pubmed: 25551239
Mol Aspects Med. 2017 Dec;58:83-92
pubmed: 28341541
Eur Neuropsychopharmacol. 2009 Jan;19(1):34-40
pubmed: 18823760
Nat Immunol. 2005 Dec;6(12):1191-7
pubmed: 16369558
Anal Chem. 2012 Feb 7;84(3):1483-90
pubmed: 22224852
Sci Transl Med. 2016 Aug 24;8(353):353ra111
pubmed: 27559094
J Clin Invest. 2018 Jul 2;128(7):2657-2669
pubmed: 29757195
Brain Res. 2016 Dec 1;1652:127-134
pubmed: 27725151
Prostaglandins Leukot Essent Fatty Acids. 2021 Jan;164:102219
pubmed: 33316626
Curr Dev Nutr. 2018 Jul 27;2(10):nzy065
pubmed: 30338310
Prostaglandins Other Lipid Mediat. 2014 Jun;109-111:23-31
pubmed: 24667634
Arch Gen Psychiatry. 2010 Mar;67(3):220-9
pubmed: 20194822
Int J Neuropsychopharmacol. 2017 Jul 1;20(7):575-584
pubmed: 28419244
Immunity. 2014 Mar 20;40(3):315-27
pubmed: 24656045
J Clin Psychiatry. 2022 Aug 22;83(5):
pubmed: 36005883
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20979-84
pubmed: 18077391
Psychopharmacology (Berl). 2018 Jan;235(1):329-336
pubmed: 29090333
Am J Physiol Regul Integr Comp Physiol. 2013 Dec;305(11):R1281-96
pubmed: 24089379
Diabetes. 2013 Jun;62(6):1945-56
pubmed: 23349501
Am J Clin Nutr. 2019 May 1;109(5):1251-1263
pubmed: 31006007
Alzheimers Dement. 2015 Jan;11(1):40-50.e1-2
pubmed: 24530025
Mol Aspects Med. 2018 Dec;64:109-134
pubmed: 29305120
Epilepsia Open. 2018 May 10;3(2):255-263
pubmed: 29881804
Mol Psychiatry. 2016 Jan;21(1):71-9
pubmed: 25802980
J Am Coll Nutr. 2009 Oct;28(5):525-42
pubmed: 20439549
Circ Res. 2020 Jan 3;126(1):75-90
pubmed: 31829100
Physiol Behav. 2016 Nov 1;166:14-21
pubmed: 26703235
Nat Rev Neurosci. 2008 Jan;9(1):46-56
pubmed: 18073775
Nat Med. 2015 Mar;21(3):239-247
pubmed: 25706874
J Immunol. 2017 Aug 9;:
pubmed: 28794232
Alzheimers Dement. 2016 Jun;12(6):719-32
pubmed: 27179961
N Engl J Med. 2019 Jan 3;380(1):11-22
pubmed: 30415628
Prostaglandins Leukot Essent Fatty Acids. 2017 Apr;119:38-44
pubmed: 28410668
Front Cardiovasc Med. 2019 Feb 28;6:16
pubmed: 30873416
J Pharmacol Sci. 2018 Sep;138(1):86-88
pubmed: 30293959
Transl Psychiatry. 2019 Aug 5;9(1):190
pubmed: 31383846
Acta Psychiatr Scand. 2017 May;135(5):373-387
pubmed: 28122130
FASEB J. 2014 Nov;28(11):4835-46
pubmed: 25059230